BioNSW has opened expressions of interest for the next BioInvest Catalyst Pitch and Networking Event, following the success of its previous sold-out gatherings, which have become key fixtures on New South Wales’ biotech investment calendar.
Sponsored by Gadens, the third event in the BioInvest Catalyst series will take place in Sydney’s CBD on Thursday, 13 November 2025, from 6:00 to 9:00 pm. Set against a Sydney Harbour backdrop, the evening will feature twelve emerging life sciences companies pitching to an audience of investors, industry leaders, and innovators.
David Atkins, Chair of the BioNSW Investment Committee, said the event continues to build momentum as a platform connecting capital with discovery. “The BioInvest Catalyst series has quickly become a highlight on the NSW biotech calendar,” he said. “It’s a rare opportunity for companies and investors to connect directly, discover fresh opportunities, and help shape the next wave of health innovation coming out of NSW.”
Building on the March and August events, the November edition will showcase early-stage deal flow and commercial opportunities that are often difficult for investors to access elsewhere. Startups and scale-ups will present technologies spanning medical devices, diagnostics, digital health, and therapeutics, with networking sessions designed to encourage direct dialogue between founders and investors.
Expressions of interest are now open for companies wishing to pitch and for investors seeking to attend. Registration details, including ticket purchases and pitch applications, are available through BioNSW’s website (event password: BICD1125).